Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

42271 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BNP Paribas : Communique AMF CP. CP24968732
PU
BNP Paribas : Communique AMF CP. CP24968729
PU
MAG Silver Announces Filing of Final Base Shelf Prospectus
AQ
Coca Cola FEMSA B de C : Form 6-K
PU
Fomento Económico Mexicano B de C : Económico Mexicano, S.A.B. de C.V. Code of Principles and Best Corporate Governance Practices Questionnaire - Form 6-K
PU
Gold Royalty : COMMON SHARE PURCHASE WARRANT GOLD ROYALTY CORP - Form 6-K
PU
Genesco : Transcript - Q1 FY2025 Conference Call
PU
Manufacturers Are "Winning" In The 340B Drug Discount Dispute
AQ
Beyond Air : Corporate Presentation
PU
Transcript : Genesco Inc., Q1 2025 Earnings Call, May 31, 2024
Novartis : Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high risk node negative disease
PU
Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML
GL
Banco Santander S A : Senior Preferred, Serie 2060
PU
Banco Santander S A : Senior Preferred, Serie 2057
PU
BNP Paribas : Communique AMF CP. CP24968566
PU
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
PR
Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
GL
X3 : STANDBY EQUITY PURCHASE AGREEMENT - Form 6-K
PU
Newmont : 2023 EEO1 Report
PU
Transcript : Life Time Group Holdings, Inc. - Analyst/Investor Day
Descartes : Announces Fiscal 2025 First Quarter Financial Results - Form 6-K
PU
Toast : EEO-1 2023
PU
BOS Reports Financial Results for the First Quarter of the Year 2024
AQ
Vast Receives Planning Consent for CSP-powered Solar Methanol Project in Port Augusta
GL
Transcript : Roivant Sciences Ltd., Q4 2024 Earnings Call, May 30, 2024
Announcement on 2024/05/30: Important Resolutions from UMC’s 2024 Annual General Meeting 99.2 Announcement on 2024/05/30: The Company’s Re-election of directors at 2024 Annual General Meeting - Form 6-K
PU
Marcus : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
NOVONIX Completes Independent Engineering Assessment of Riverside Facility
GL
Enlivex Therapeutics : Immediate Report
PU
Descartes Announces Fiscal 2025 First Quarter Financial Results
GL
Pure Storage Announces First Quarter Fiscal 2025 Financial Results
PR
Verve Therapeutics : An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves precise, and durable liver editing in nonclinical studies
PU
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
AQ
D-Wave Quantum Featured in The Wall Street Journal
BU
Western Uranium & Vanadium : NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 8-K
PU
Navigating Legal Rights And Responsibilities In Employment Agreements In Alberta (Part 3)
AQ
Ventas : May Business Update
PU
Gold Royalty : UNDERWRITING AGREEMENT - Form 6-K
PU
Nouveau Monde Graphite : YOUR VOTE AS A SHAREHOLDER IS IMPORTANT. VOTE TODAY - Form 6-K
PU
Royal Caribbean : EEO-1 RCG US (Sustainability Report)
PU
Standard Lithium : MESSAGE FROM OUR CEO - Form 6-K
PU
GlobalFoundries : ORDINARY SHARES, PAR VALUE $0.02 PER SHARE UNDERWRITING AGREEMENT - Form 6-K
PU
Alamos Gold : AMENDMENT NO. 1 TO ARRANGEMENT AGREEMENT - Form 6-K
PU
Southern Arc Minerals : Management Information Circular
PU
Danaos : 2023 Annual Report Annual Report
PU
D-Wave Quantum Set to Join Russell 3000® Index
BU
Companhia Brasileira de Distribuiçao Netherlands B : CHAPTER I NAME, HEADQUARTERS, PURPOSE, AND DURATION - Form 6-K
PU
Honda Motor : GIKEN KOGYO KABUSHIKI KAISHA - Form 6-K
PU
"LEQEMBI" Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea
AQ
Ser Educacional S A : Minutes of Board of Directors Meeting Held on May 27, 2024
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. J. Forth
  4. News